Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low dose hydrocortisone in patients with COVID-19 and severe hypoxia – COVID STEROID trial
2020-001395-15Phase 3Terminated
- Sponsor
- Rigshospitalet
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Hydrocortisone arm with Placebo arm (2 arms). Primary endpoint: Days alive without life support to day 28. Started Mar 2020; status: terminated.
02
Drugs
hydrocortisone sodium succinate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001395-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001395-15.